Orapharma Drug Patent Portfolio
Orapharma owns 1 orange book drug protected by 2 US patents Given below is the list of Orapharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6682348 | Dispensing apparatus and cartridge | 29 Mar, 2022 | Expired |
| US7699609 | Dispensing apparatus and cartridge with deformable tip | 29 Mar, 2022 | Expired |
Latest Legal Activities on Orapharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orapharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Sep, 2021 | US7699609 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 27 Sep, 2017 | US7699609 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Apr, 2010 | US7699609 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Apr, 2010 | US7699609 |
|
Email Notification
Critical
| 01 Apr, 2010 | US7699609 |
|
Issue Notification Mailed
Critical
| 31 Mar, 2010 | US7699609 |
| Dispatch to FDC | 10 Mar, 2010 | US7699609 |
|
Application Is Considered Ready for Issue
Critical
| 09 Mar, 2010 | US7699609 |
|
Issue Fee Payment Verified
Critical
| 02 Mar, 2010 | US7699609 |
|
Issue Fee Payment Received
Critical
| 02 Mar, 2010 | US7699609 |
|
Electronic Review
Critical
| 13 Jan, 2010 | US7699609 |
|
Email Notification
Critical
| 13 Jan, 2010 | US7699609 |
|
Mail Notice of Allowance
Critical
| 13 Jan, 2010 | US7699609 |
|
Notice of Allowance Data Verification Completed
Critical
| 09 Jan, 2010 | US7699609 |
| Date Forwarded to Examiner | 10 Oct, 2009 | US7699609 |
Orapharma's Family Patents
Orapharma drugs have patent protection in a total of 13 countries. It's US patent count contributes only to 17.6% of its total global patent coverage. 8 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Orapharma Drug List
Given below is the complete list of Orapharma's drugs and the patents protecting them.
1. Arestin
Arestin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6682348 | Dispensing apparatus and cartridge |
29 Mar, 2022
(2 years ago)
| Expired |
| US7699609 | Dispensing apparatus and cartridge with deformable tip |
29 Mar, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arestin's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List